This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Nomura (NMR) Ups Profit Target Despite Incurring Archegos Loss
by Zacks Equity Research
Nomura (NMR) raises its pretax income target for the next fiscal year by 14.3% despite taking a nearly $3-billion hit from the Archegos collapse.
Credit Suisse & Others Tighten Lending Terms in Archegos Collapse
by Zacks Equity Research
Banks like Credit Suisse (CS), Morgan Stanley (MS), Nomura (NMR) and UBS Group (UBS) are tightening lending terms of some of their hedge fund clients to prevent events like the Archegos collapse.
NMR vs. SCHW: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
NMR vs. SCHW: Which Stock Is the Better Value Option?
Nomura (NMR) to Conduct Investigation on Archegos-Related Loss
by Zacks Equity Research
Nomura Holdings (NMR) is reviewing deficiencies in risk management processes that resulted in the company taking about $2 billion financial hit.
Credit Suisse (CS) Expects to Report Q1 Loss on Archegos Fallout
by Zacks Equity Research
Credit Suisse (CS) projects a CHF 4.4 billion financial hit on account of the Archegos Capital Management crisis.
NMR vs. WETF: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
NMR vs. WETF: Which Stock Is the Better Value Option?
Credit Suisse (CS) & Nomura (NMR) Outlook Downgraded by Moody's
by Zacks Equity Research
Deficiencies in risk management processes result in outlook downgrade for Credit Suisse Group (CS) & Nomura Holdings' (NMR) by Moody's.
Mitsubishi UFJ (MUFG) Raises Profit Guidance for FY2021
by Zacks Equity Research
Progress in business performance and improvement in securities unit led Mitsubishi UFJ (MUFG) to raise its profit target for fiscal 2021.
Credit Suisse's (CS) Outlook Downgraded on Archegos Default
by Zacks Equity Research
S&P Global Ratings downgrades outlook on Credit Suisse (CS) to negative as the Swiss bank expects to take a major financial hit on account of the Archegos Capital Management crisis.
Mitsubishi UFJ (MUFG) Expects $300M Hit From Archegos Episode
by Zacks Equity Research
The securities arm of Mitsubishi UFJ (MUFG) continues to measure the amount of loss it may experience as Archegos defaulted on its margin call.
Credit Suisse (CS), Nomura (NMR) to be Hit by Archegos' Default
by Zacks Equity Research
First-quarter results of Credit Suisse (CS) and Nomura (NMR) will likely reflect the impact of Archegos defaulting on its margin call.
Stock Market News for Mar 30, 2021
by Zacks Equity Research
Markets ended mostly lower on Monday, with bank stocks tumbling on concerns of potential losses from a hedge fund after it was compelled to sell huge holdings in stocks.
Nomura (NMR): Strong Industry, Solid Earnings Estimate Revisions
by Zacks Equity Research
Nomura (NMR) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
NMR vs. TW: Which Stock Is the Better Value Option?
by Zacks Equity Research
NMR vs. TW: Which Stock Is the Better Value Option?
Nomura (NMR): Strong Industry, Solid Earnings Estimate Revisions
by Zacks Equity Research
Nomura (NMR) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
NMR vs. TW: Which Stock Is the Better Value Option?
by Zacks Equity Research
NMR vs. TW: Which Stock Is the Better Value Option?
NMR vs. TW: Which Stock Is the Better Value Option?
by Zacks Equity Research
NMR vs. TW: Which Stock Is the Better Value Option?
Nomura (NMR) to Bolster Wealth and Fixed Income Units in Asia
by Zacks Equity Research
Nomura (NMR) seeks to benefit from relatively higher interest rates in the Asian region by hiring more employees in the Wealth and Fixed Income departments.
Top Ranked Value Stocks to Buy for November 30th
by Zacks Equity Research
Here are three stocks with buy rank and strong value characteristics for investors to consider today, November 30th.
NMR vs. TW: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
NMR vs. TW: Which Stock Is the Better Value Option?
Top Ranked Value Stocks to Buy for November 25th
by Zacks Equity Research
Here are three stocks with buy rank and strong value characteristics for investors to consider today, November 25th.
Top Ranked Value Stocks to Buy for November 20th
by Zacks Equity Research
Here are four stocks with buy rank and strong value characteristics for investors to consider today, November 20th.
Top Ranked Value Stocks to Buy for November 18th
by Zacks Equity Research
Here are three stocks with buy rank and strong value characteristics for investors to consider today, November 18th.
Is Nomura Holdings (NMR) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Top Ranked Value Stocks to Buy for November 10th
by Zacks Equity Research
Here are four stocks with buy rank and strong value characteristics for investors to consider today, November 10th.